The Acetazolamide market was valued at xxx million USD with a CAGR xx% from 2015-2019. Subsequently, it will touch xxx million USD in 2020 with a CAGR xx % from 2020 to 2025.
Acetazolamide, sold under the trade name Diamox among others, is a medication used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, idiopathic intracranial hypertension, and heart failure. It may be used long term for the treatment of open angle glaucoma and short term for acute angle closure glaucoma until surgery can be carried out. It is taken by mouth or injection into a vein.
In the global Acetazolamide market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the market on the basis of application, type, regions, and manufactures.
In global market, the following companies are covered:
Teva
TARO
Zydus Pharmaceuticals
Lannett Company
Sun Pharmaceutical
Heritage Pharmaceuticals
Nostrum Laboratories
Accord Healthcare
Strides Pharma
West-Ward Pharmaceuticals
X-Gen Pharmaceuticals
Mylan
Emcure
Market Segment by Product Type
Tablets
Capsule
Injection
Market Segment by Application
Hospital
Drug store
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Acetazolamide market for the forecast period 2020 - 2025?
• What are the driving forces in the Acetazolamide market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Acetazolamide industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?